JP2003508441A5 - - Google Patents

Download PDF

Info

Publication number
JP2003508441A5
JP2003508441A5 JP2001519915A JP2001519915A JP2003508441A5 JP 2003508441 A5 JP2003508441 A5 JP 2003508441A5 JP 2001519915 A JP2001519915 A JP 2001519915A JP 2001519915 A JP2001519915 A JP 2001519915A JP 2003508441 A5 JP2003508441 A5 JP 2003508441A5
Authority
JP
Japan
Prior art keywords
drospirenone
daily dose
ethinyl estradiol
composition
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001519915A
Other languages
English (en)
Japanese (ja)
Other versions
JP4354667B2 (ja
JP2003508441A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2000/001213 external-priority patent/WO2001015701A1/en
Publication of JP2003508441A publication Critical patent/JP2003508441A/ja
Publication of JP2003508441A5 publication Critical patent/JP2003508441A5/ja
Application granted granted Critical
Publication of JP4354667B2 publication Critical patent/JP4354667B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001519915A 1999-08-31 2000-08-31 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ Expired - Lifetime JP4354667B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38627499A 1999-08-31 1999-08-31
EP99202826 1999-08-31
EP99202826.6 1999-08-31
US09/386,274 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009048381A Division JP2009143959A (ja) 1999-08-31 2009-03-02 避妊薬として使用するためのエチニルエストラジオールとドロスピレノンとの組合せ剤

Publications (3)

Publication Number Publication Date
JP2003508441A JP2003508441A (ja) 2003-03-04
JP2003508441A5 true JP2003508441A5 (https=) 2005-12-22
JP4354667B2 JP4354667B2 (ja) 2009-10-28

Family

ID=26153359

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001519915A Expired - Lifetime JP4354667B2 (ja) 1999-08-31 2000-08-31 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ
JP2009048381A Pending JP2009143959A (ja) 1999-08-31 2009-03-02 避妊薬として使用するためのエチニルエストラジオールとドロスピレノンとの組合せ剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009048381A Pending JP2009143959A (ja) 1999-08-31 2009-03-02 避妊薬として使用するためのエチニルエストラジオールとドロスピレノンとの組合せ剤

Country Status (26)

Country Link
EP (4) EP2044941A1 (https=)
JP (2) JP4354667B2 (https=)
KR (2) KR101019361B1 (https=)
AT (3) ATE254464T1 (https=)
AU (4) AU780330B2 (https=)
BG (1) BG66114B1 (https=)
BR (1) BR0014159A (https=)
CY (3) CY1108990T1 (https=)
CZ (1) CZ300514B6 (https=)
DE (5) DE60042089D1 (https=)
DK (3) DK1214076T3 (https=)
EE (1) EE05128B1 (https=)
ES (3) ES2211580T3 (https=)
HK (1) HK1047247B (https=)
HR (1) HRP20070188B1 (https=)
HU (1) HU227207B1 (https=)
IL (1) IL148339A0 (https=)
ME (2) MEP36008A (https=)
NO (1) NO326860B1 (https=)
NZ (1) NZ517845A (https=)
PL (1) PL199028B1 (https=)
PT (3) PT1214076E (https=)
RS (3) RS50262B (https=)
SI (3) SI1214076T1 (https=)
TW (1) TWI276436B (https=)
WO (1) WO2001015701A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1214076T1 (en) * 1999-08-31 2004-06-30 Schering Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
ATE442147T1 (de) * 2000-01-18 2009-09-15 Bayer Schering Pharma Ag Pharmazeutische zubereitung enthaltend drospirenon
JO2334B1 (en) * 2000-01-18 2006-06-28 باير شيرنغ فارما اكتنجيسيلشافت Drospirenone for hormone replacement therapy
JP5350572B2 (ja) * 2000-12-20 2013-11-27 バイエル ファーマ アクチエンゲゼルシャフト シクロデキストリン−ドロスピレノン封入複合体
EP1216713A1 (en) 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
HK1079997A1 (zh) * 2002-04-26 2006-04-21 舍林股份公司 治疗接受激素替代疗法之妇女中的高血压的方法
US7786101B2 (en) 2002-11-05 2010-08-31 Bayer Schering Pharma Ag Cardiovascular protection using anti-aldosteronic progestins
BRPI0508612A (pt) * 2004-03-10 2007-08-14 Schering Aktiengellschaft composições compreendendo drospirenona dispersa molecularmente
MY142989A (en) 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
JP2008534522A (ja) * 2005-03-30 2008-08-28 ジェンファーム インク 医薬組成物のための複合ステップ製造方法
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
EP1767194A1 (de) * 2005-06-09 2007-03-28 Helm AG Verfahren zur Herstellung von Adsorbaten des Drospirenons
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
EP1900359A1 (en) * 2006-09-16 2008-03-19 KAIROSmed GmbH Oral modified release formulations containing drospirenon and 8-prenylnaringenin for use in female contraception
WO2008031631A2 (en) * 2006-09-16 2008-03-20 Bayer Schering Pharma Aktiengesellschaft Oral modified release formulations
US20090023693A1 (en) * 2007-04-05 2009-01-22 Vladimir Hanes New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
HUP0700826A3 (en) 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
TW200942242A (en) * 2008-03-10 2009-10-16 Rolf Schurmann New drospirenone/17β-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
WO2009112232A2 (en) * 2008-03-10 2009-09-17 Vladimir Hanes New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
EP2398461A1 (en) 2009-02-18 2011-12-28 Bayer Pharma Aktiengesellschaft Formulation comprising drospirenone for subcutaneous or intramuscular administration
UY32836A (es) 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
US20130137664A1 (en) * 2010-04-15 2013-05-30 Bayer Intellectual Property Gmbh Low-dosed solid oral dosage forms for hrt
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
IT202100008834A1 (it) 2021-04-08 2022-10-08 Ind Chimica Srl Processo per la preparazione di drospirenone come polvere fine tramite duplice cambio di forma cristallina
WO2023152658A1 (en) 2022-02-10 2023-08-17 Lupin Limited Slow release drospirenone tablet composition
EP4486311A1 (en) * 2022-03-01 2025-01-08 Chemo Research, S.L. Chewable oral contraceptive

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3051168C2 (de) * 1979-01-24 1998-08-27 Minnesota Mining & Mfg Mono- bzw. Polycarbonsäureester oder deren Gemische oder Ester bzw. deren Gemische aus Isocyanaten und fluor- bzw. chlorhaltigen aliphatischen Alkoholen
DE3051166C2 (en) 1980-06-11 1990-10-18 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De Compsns. for contraception or treatment of gynaecological disorders
DE3347125A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
EP0209403B1 (en) * 1985-07-15 1991-10-23 Research Development Corporation of Japan Process for preparing ultrafine particles of organic compounds
DE3916112A1 (de) 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE4227989A1 (de) 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DK95093D0 (da) * 1993-08-20 1993-08-20 Novo Nordisk As Farmaceutisk formulering indeholdende et hormon
ZA939566B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for dry blend compression od medicaments.
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
JP4334616B2 (ja) * 1994-09-22 2009-09-30 ナームローゼ・フエンノートチヤツプ・オルガノン 湿式粒状化による投与単位体を製造する方法
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US5922349A (en) * 1995-09-28 1999-07-13 Schering Aktiengesellschaft Hormone replacement therapy method and hormone dispenser
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
SI0917466T1 (en) * 1996-07-26 2005-02-28 Wyeth Oral contraceptive
WO1998004267A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
KR100518102B1 (ko) * 1996-07-26 2005-10-04 와이어쓰 프로게스틴과 에스트로겐의 혼합물을 포함하는 단일상 피임약 키트
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
SI1214076T1 (en) * 1999-08-31 2004-06-30 Schering Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
ATE442147T1 (de) * 2000-01-18 2009-09-15 Bayer Schering Pharma Ag Pharmazeutische zubereitung enthaltend drospirenon

Similar Documents

Publication Publication Date Title
JP2003508441A5 (https=)
EP1611892B1 (en) Pharmaceutical compositions comprising drospirenone
ES2319750T3 (es) Composicion farmaceutica que comprende etinilestradiol y drospirenona para usar como anticonceptivo.
ES2402544T3 (es) Preparación pelicular rápidamente soluble
TWI234459B (en) Eplerenone compositions
US20140050794A1 (en) Pharmaceutical composition for use as a contraceptive
RU2482853C2 (ru) Фармацевтическая композиция, способ ее получения и многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего
US3428728A (en) Timed release sublingual medications
EP4014978B1 (en) Combination product containing a limonoid compound and acarbose
WO2000043017A1 (en) Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
WO2005084392A2 (en) 4-methylpyrazole formulations for inhibiting ethanol intolerance
CN101015519A (zh) 一种氯雷他定口服复方药物组合物
RU2002107987A (ru) Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
CN101897709A (zh) 含有小剂量叶酸和阿司匹林的药物组合物及其用途
JP3187914B2 (ja) アミラーゼ阻害物質
CN101564394B (zh) 含有伊伐布雷定和曲美他嗪的药物组合物
CN105833051B (zh) 一种护心通络的药物组合物及含其制剂与应用
CN114401724B (zh) 一种降糖药物组合物
CN103690524A (zh) 淫羊藿素在制备防治脑血管疾病药物中的应用
HK40066301B (en) Combination product containing a limonoid compound and acarbose
CN101869572A (zh) 含有双胍类降糖药物和普利类降压药物的组合物及其用途
CN102335204A (zh) 一种中药制剂金水宝丸及其制备方法
HK1082433B (en) Pharmaceutical compositions comprising drospirenone
HK1082432B (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
HK1061968B (en) Pharmaceutical combination of ethinylestradiol and dropirenone for use as a contraceptive